Nicholas Investment Partners, LP Iveric Bio, Inc. Transaction History

Nicholas Investment Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$26.24 - $39.63 $8.54 Million - $12.9 Million	325,548 New	325,548 $12.8 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $10.2 Million - $20.1 Million	-1,080,077 Reduced 83.72%	209,976 $3.77 Million
Q2 2022 Aug 10, 2022	BUY	$9.12 - $18.9 $1.79 Million - $3.71 Million	196,377 Added 17.96%	1,290,053 $12.4 Million
Q1 2022 May 10, 2022	BUY	$12.15 - $16.83 $6.73 Million - $9.32 Million	553,946 Added 102.63%	1,093,676 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $7.46 Million - $10.1 Million	539,730 New	539,730 $9.02 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.